Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study

Authors
Category Primary study
Conference2024 ISPE Annual Meeting
Year 2024
This article has no abstract
Epistemonikos ID: cdd99e019092401b0e7d112b248112302b2108f4
First added on: Jan 20, 2026